{"id":51305,"date":"2023-09-20T09:20:09","date_gmt":"2023-09-20T09:20:09","guid":{"rendered":"https:\/\/medsname.com\/latoprost-eye-drop\/"},"modified":"2026-04-30T10:25:29","modified_gmt":"2026-04-30T10:25:29","slug":"latoprost-eye-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/latoprost-eye-drop\/","title":{"rendered":"Latoprost Eye Drop"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 Quick Answer \u2014 What is Latoprost Eye Drop?<\/h3>\n<p style=\"margin:0;\">Latoprost Eye Drop is Latanoprost 0.005%, a once-daily prostaglandin eye drop that lowers eye pressure 25\u201333% in glaucoma. Apply one drop to each affected eye in the evening. Watch for iris darkening and eyelash growth.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">Why order from MedsBase?<\/strong> Sourced from a WHO-GMP certified manufacturer \u00b7 Discreet packaging \u00b7 Worldwide Shipping \u00b7 <a href=\"\/reviews\/\" rel=\"noopener\">1,400+ verified customer reviews<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Every order is covered by our <a href=\"https:\/\/medsbase.com\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n<h3>Why order from MedsBase<\/h3>\n<p>Latoprost Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our <a href=\"\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">Reshipment Assurance Policy<\/a> \u2014 if it has not arrived after 20 business days we reship at no extra cost. Backed by 1,400+ verified customer reviews.<\/p>\n<h2>What is Latoprost Eye Drop?<\/h2>\n<p>Latoprost Eye Drop is manufactured by Ajanta Pharma and contains Latanoprost 0.005% as a sterile ophthalmic solution. Latoprost Eye Drop 0.005% is a prostaglandin F2&alpha; analog used to lower raised intra-ocular pressure (IOP) in open-angle glaucoma and ocular hypertension. It is one of the most potent IOP-lowering eye drops available \u2014 typical reduction is 25\u201333% from baseline. The 3 mL bottle contains benzalkonium chloride preservative \u2014 patients with significant sensitivity should consider preservative-free alternatives. <\/p>\n<h2>How Latanoprost Works<\/h2>\n<p>Latanoprost is a synthetic structural analogue of prostaglandin F2&alpha;. It binds the FP prostanoid receptor in the ciliary body, increasing uveoscleral outflow (the secondary drainage pathway for aqueous humour). Because it works on the outflow side of the equation rather than reducing aqueous production, it is additive with beta-blockers, alpha-2 agonists, and carbonic anhydrase inhibitors. The lash-growth effect comes from FP-receptor activation in the dermal papilla of the eyelash follicle, which prolongs anagen phase and thickens individual hair shafts.<\/p>\n<h2>Indications<\/h2>\n<ul>\n<li><strong>Open-angle glaucoma:<\/strong> first-line monotherapy for newly diagnosed primary open-angle glaucoma (POAG) per AAO Preferred Practice Pattern 2020.<\/li>\n<li><strong>Ocular hypertension:<\/strong> when IOP is consistently &gt; 21 mmHg with risk factors (thin cornea, family history, African or Hispanic ancestry).<\/li>\n<li><strong>Eyelash hypotrichosis<\/strong> (bimatoprost only \u2014 Latisse indication): cosmetic lash enhancement.<\/li>\n<li><strong>Add-on therapy<\/strong> when first-line agent does not reach target IOP \u2014 additive with timolol, brimonidine, dorzolamide.<\/li>\n<\/ul>\n<h2>Dosing &amp; Administration<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">Indication<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">Dose<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">POAG \/ ocular hypertension<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 drop in affected eye(s) once daily, in the evening<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">If a dose is missed<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Skip and resume normal schedule next evening \u2014 do not double up<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">More than one drop?<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Adding a second drop does not increase IOP-lowering \u2014 it actually reduces efficacy by saturating receptors. Strictly one drop per eye.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Multiple eye drops<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Wait at least 5 minutes between different eye-drop products to avoid washout<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Contact lenses<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Remove before instillation; reinsert 15 minutes after<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Side Effects<\/h2>\n<p><strong>Common (5\u201315%):<\/strong> ocular redness (conjunctival hyperaemia), eyelash thickening \/ lengthening \/ darkening, ocular pruritus, mild stinging on instillation, dry eye sensation.<\/p>\n<p><strong>Cosmetically notable:<\/strong><\/p>\n<ul>\n<li><strong>Iris pigmentation<\/strong> (1\u20132% over months to years): permanent darkening of light-coloured (blue, green, hazel) irises by stimulating iris stromal melanocytes. Brown irises usually unaffected. Lashes and periorbital skin may also darken.<\/li>\n<li><strong>Periorbital fat atrophy \/ prostaglandin-associated periorbitopathy (PAP):<\/strong> deepening of the upper-lid sulcus, eyelid ptosis, enophthalmos. Most reported with bimatoprost &gt; travoprost &gt; latanoprost. Usually reversible 3\u20136 months after stopping.<\/li>\n<li><strong>Periorbital skin pigmentation:<\/strong> reversible darkening of lid\/peri-orbital skin from drug runoff.<\/li>\n<\/ul>\n<p><strong>Less common:<\/strong> cystoid macular oedema (CME) \u2014 especially in pseudophakic eyes or those with macular pathology; uveitis re-activation in patients with a history of uveitis; reactivation of herpes simplex keratitis.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Iris pigmentation is permanent.<\/strong> Patients with blue, green, or hazel eyes who use a prostaglandin analog long-term may develop irreversible darkening of the iris (especially asymmetric if treating only one eye). Discuss this risk before starting if cosmetic concern matters to you.<\/div>\n<h2>Warnings &amp; Contraindications<\/h2>\n<ul>\n<li><strong>Active uveitis or iritis<\/strong> \u2014 relative contraindication; can re-activate intraocular inflammation<\/li>\n<li><strong>Pseudophakic eyes with torn posterior capsule, aphakia, or known macular oedema risk<\/strong> \u2014 increased risk of cystoid macular oedema<\/li>\n<li><strong>Active herpes simplex keratitis<\/strong> \u2014 may reactivate viral disease<\/li>\n<li><strong>Pregnancy \/ breastfeeding<\/strong> \u2014 Category C; avoid unless benefit clearly outweighs risk (theoretical uterine smooth-muscle activity)<\/li>\n<li><strong>Children &lt; 16 years<\/strong> \u2014 safety not established for cosmetic lash use<\/li>\n<\/ul>\n<h2>Storage<\/h2>\n<p>Store at room temperature (15\u201325\u00b0C \/ 59\u201377\u00b0F) away from direct sunlight. Do not freeze. Discard 28 days after first opening. Keep the bottle tightly capped between uses to prevent contamination.<\/p>\n<h2 id=\"faqs\">Frequently Asked Questions<\/h2>\n<h3>How long until I see results from Latoprost Eye Drop?<\/h3>\n<p>For glaucoma, IOP reduction begins within 4 hours of the first dose with maximum effect at 8\u201312 hours; steady-state IOP is reached at 4 weeks. For lash growth (bimatoprost), visible thickening at 4 weeks and full lash growth at 16 weeks.<\/p>\n<h3>What if I forget a dose?<\/h3>\n<p>Skip the missed dose and resume your normal once-nightly schedule. Do not double up \u2014 using two drops at once actually reduces efficacy because of receptor saturation.<\/p>\n<h3>Why does Latanoprost darken eye colour?<\/h3>\n<p>Latanoprost activates the FP prostanoid receptor on iris stromal melanocytes, stimulating melanin production. Lighter irises (blue, green, hazel) contain less baseline melanin and so show change more readily. The effect is permanent and may be asymmetric if only one eye is treated.<\/p>\n<h3>Can I use Latoprost Eye Drop if I wear contact lenses?<\/h3>\n<p>Yes, but remove your contacts before instillation and wait 15 minutes before re-inserting. The benzalkonium chloride preservative can be absorbed by soft lenses and cause irritation.<\/p>\n<h3>Is Latoprost Eye Drop safe in pregnancy?<\/h3>\n<p>Category C. Theoretical concerns about prostaglandin effects on uterine smooth muscle. Discuss with your ophthalmologist \u2014 most clinicians switch to a beta-blocker or brimonidine during pregnancy, or pause cosmetic lash use entirely.<\/p>\n<h3>What happens if I stop using Latoprost Eye Drop?<\/h3>\n<p>For glaucoma, IOP returns to baseline within 4 weeks of stopping. For cosmetic lash use, lashes return to their pre-treatment length and density 4\u20138 weeks after stopping. Iris darkening, however, is permanent.<\/p>\n<h3>Can I use Latoprost Eye Drop on my lower lashes?<\/h3>\n<p>No. The product is approved for upper-lash-line application only. Lower-lash application creates excessive runoff onto the cheek, increasing the risk of unwanted hair growth on skin and skin pigmentation changes.<\/p>\n<h3>Does Latoprost Eye Drop cause periorbital changes?<\/h3>\n<p>Yes \u2014 prostaglandin-associated periorbitopathy (PAP) describes the syndrome of deepening upper-lid sulcus, ptosis, and enophthalmos seen in 5\u201325% of long-term users. Bimatoprost has the highest reported rate; latanoprost the lowest. Usually reversible 3\u20136 months after stopping.<\/p>\n<h3>Can Latoprost Eye Drop be combined with other glaucoma drops?<\/h3>\n<p>Yes \u2014 prostaglandin analogs are additive with beta-blockers, alpha-2 agonists, and carbonic anhydrase inhibitors because they target the outflow side. Wait 5 minutes between different drops. Fixed combinations such as bimatoprost+timolol exist for adherence.<\/p>\n<h3>What is the difference between Latanoprost and other prostaglandins?<\/h3>\n<p>All three (latanoprost, travoprost, bimatoprost) lower IOP 25\u201333%. Latanoprost has the gentlest side-effect profile. Travoprost has a slightly higher response rate. Bimatoprost is the most potent for both IOP and lash growth, but with the highest rate of conjunctival hyperaemia and PAP.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Other Eye-Care Medications<\/h3>\n<p>Customers viewing this product also consider these alternatives in our <a href=\"\/eye-care\/\">Eye Care<\/a> range:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/xalatan-eye-drop\/\">Xalatan Eye Drop (latanoprost)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/azopt-eye-drops\/\">Azopt Eye Drops (brinzolamide)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/alphagan-p-drop\/\">Alphagan P Drop (brimonidine)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/iotim-eye-drops\/\">Iotim Eye Drops (timolol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/careprost-eye-drops\/\">Careprost (bimatoprost)<\/a><\/li>\n<\/ul>\n<h3>Medical Disclaimer<\/h3>\n<p style=\"font-size:13px;color:#555;\">The information on this page is for educational purposes only and is not a substitute for medical advice from a qualified ophthalmologist or optometrist. Eye conditions can rapidly threaten sight \u2014 sudden vision loss, severe pain, or trauma is an ophthalmology emergency. Always consult an eye-care professional before starting, stopping, or changing any treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Latoprost (latanoprost 0.005%) \u2014 once-daily prostaglandin analogue for open-angle glaucoma and ocular hypertension. First-line IOP-lowering monotherapy. Bedtime dose.<\/p>\n","protected":false},"featured_media":51306,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[],"class_list":{"0":"post-51305","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product\/51305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/comments?post=51305"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media\/51306"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media?parent=51305"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_brand?post=51305"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_cat?post=51305"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_tag?post=51305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}